Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 580 results for "ranbaxy industries"

Top Pharma news of the day
India Infoline

Top Pharma news of the day

Sun Pharmaceutical Industries is cutting staff again as it digests the $3.2-billion acquisition of Ranbaxy Laboratories. Facing the axe this time are research and development staff, a move that comes a month after about 150 senior executives were asked to ... India Infoline, 1 month ago

Sun Pharma warns on revenue, profit due to Ranbaxy takeover [Mint, New Delhi]

July 21--MUMBAI -- Sun Pharmaceutical Industries Ltd India's largest drugmaker by sales said it expects consolidated revenue to either remain flat or show a decline from a year earlier. "As a part of the integration process, the company expects to ...
 Bloomberg1 month ago Sun Pharma Takes One-Time Charge as Sales Miss Estimates  Bloomberg2 weeks ago Sun Pharma Q1 net profit down 60 pct at Rs 478.96 crore  Financial Express2 weeks ago Sun Pharma net profit falls 60% to Rs.479 crore  Livemint.com2 weeks ago

Slowdown in US sales, Ranbaxy integration weigh on Sun Pharma

MUMBAI: Sun Pharmaceutical Industries on Tuesday posted results in line with what it had warned, as a drop in US sales and the integration of Ranbaxy Laboratories weighed on financial performance of the nation's top drug maker. Net profit for the quarter ...
 Economic Times2 weeks ago

RIL, BPCL, NTPC and Ranbaxy to see some action today

You are here ยป Indian-Commodity : Top News : 19-Nov 2013 Reliance Industries (RIL) will have to provide a bank guarantee of $135 million every quarter to get a higher price for natural gas from April 1 next year. The bank guarantee will be ...
 Indian-Commodity4 weeks ago ONGC, Engineers India and Coal India to see some action today  Indian-Commodity4 weeks ago

India's Sun Pharma sees multiyear earnings hit as it fixes plants, integrates Ranbaxy

Sun Pharma Managing Director Dilip Shanghvi Sun Pharmaceutical Industries founder and managing director Dilip Shanghvi said earlier this year his first priority after the purchase of Ranbaxy Laboratories was to solve regulatory and integration ...
 Fierce Biotech IT1 month ago Sun Pharma MD Dilip Shanghvi expects own products in 2-3 yrs  Business Standard India1 month ago Sun Pharma slumps 15%; warned on earnings growth for FY16  India Infoline1 month ago

Sun Pharma cuts projections on integration of Ranbaxy

Sun Pharmaceutical Industries, a Rs. 27,000 crore Indian pharma giant after merging Ranabxy Laboratories, has cut down its sales and profit projections for the year ended March 2015 on account of amalgamation of Ranbaxy Laboratories. The sales are ...
 PharmaBiz1 month ago

Sun Pharma asks some Ranbaxy employees to leave, post merger

Press Trust of India | New Delhi June 18, 2015 Last Updated at 16:13 IST Sun Pharmaceutical Industries has started easing out excess employees from Ranbaxy, including senior executives, following completion of its USD 4 billion acquisition of the ...
 Business Standard2 months ago Top executives in Ranbaxy shown the door as Sun Pharma takes charge  DNA2 months ago

Ex-Ranbaxy top executive rolls out drug delivery startup [India Business] [Times of India]

MUMBAI: Pharma industry veteran Rajiv Gulati, who quit last year as president Ranbaxy, is floating a start-up which offers a 'mail order service' for chronic medicines, particularly for patients suffering from hypertension and diabetes. mChemist ...
 Pharmacy Choice1 month ago Ex-Ranbaxy top executive Rajiv Gulati rolls out drug delivery startup  Economic Times1 month ago
Business Standard

No decision on plant closures but will optimise network: Sun Pharma

Sun Pharmaceutical Industries, which recently completed a $3.2-billion acquisition of Ranbaxy Laboratories, is considering rationalising its manufacturing network. Of the combined entity's 45 manufacturing plants, 21 are Ranbaxy's. Chief Financial ...
 Smart Investor1 month ago

Sun Pharma shares rise; HSBC says buy, Ranbaxy Halol key

Shares of Sun Pharmaceutical Industries advanced more than 1 percent intraday Thursday. Brokerage HSBC advises buying the stock with a target price of Rs 1,043. The brokerage says US sales contribution increased marginally to 90 percent, driven ...
 Moneycontrol.com2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less